PT Brigit Biofarmaka Technologi Tbk (IDX:OBAT)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
505.00
-30.00 (-5.61%)
At close: May 2, 2025, 3:30 PM WIB

IDX:OBAT Cash Flow Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
29,42611,97412,38415,649
Depreciation & Amortization
2,3292,1001,273742.44
Other Operating Activities
-18,792-57.2815.82,257
Operating Cash Flow
12,96214,01714,47318,648
Operating Cash Flow Growth
-7.52%-3.15%-22.39%-
Capital Expenditures
-6,607-7,488-7,325-3,740
Cash Acquisitions
-606.87250--
Investment in Securities
178.7920.26-375.08-
Other Investing Activities
-1,815-250-22535
Investing Cash Flow
-8,850-7,468-7,925-3,705
Short-Term Debt Issued
--5,978-
Long-Term Debt Issued
8,2104,375--
Total Debt Issued
8,2104,3755,978-
Short-Term Debt Repaid
----5,582
Long-Term Debt Repaid
-588.43-75--
Total Debt Repaid
-588.43-75--5,582
Net Debt Issued (Repaid)
7,6224,3005,978-5,582
Issuance of Common Stock
19,500-1,500-
Common Dividends Paid
-25,050-7,850-15,000-8,000
Other Financing Activities
-3,800---
Financing Cash Flow
-1,728-3,550-7,522-13,582
Miscellaneous Cash Flow Adjustments
--0-
Net Cash Flow
2,3842,998-974.191,361
Free Cash Flow
6,3556,5287,14814,908
Free Cash Flow Growth
-2.65%-8.67%-52.05%-
Free Cash Flow Margin
5.27%11.47%18.57%39.38%
Free Cash Flow Per Share
10.5915.1815.4432.20
Cash Interest Paid
1,3811,253845.28279.34
Levered Free Cash Flow
-2,6582,9953,865-
Unlevered Free Cash Flow
-1,7953,7794,393-
Change in Net Working Capital
21,128-99.93-1,938-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.